AMS electronic Patient Reported Outcomes (AMS-ePRO®)

AMS-ePRO® supports Clinical Research

You can now capture your patients data Anytime Anywhere with AMS-ePRO® to provide you with more clinically relevant data to help your trial move.

AMS has a 20 year success record of supporting many pharmaceutical, biotechnology and medical device companies in running clinical trials of all phases, indications and complexities. As clinical research evolves, and patient engagement is increasingly important, AMS has developed a fully validated electronic ePRO solution.

AMS-ePRO® system is a fully validated electronic solution which not only conforms with GCP and GDPR, but is flexible and more accommodating for the patients as they can utilize their own device. AMS has successfully utilized AMS-ePRO® in several studies in different indications.

AMS-ePRO® - flexible solutions

Collect what you want! Anywhere Anytime

Collect Patient Reported Outcomes:

  • Patient diaries: simple or complex
  • Quality of life or health related quality of life data. QOL, HQRL
  • Surveys
  • Geofencing, site-triggered calls, reminders.

Bring Your own Device – Concept

Internet-based Data Collection with patient own devices (e.g. smartphones, tablets or computers)

System fully validated

according to international computer system validation
standards (21 CFR part 11 and Annex 11)

System GDPR Compliant

in accordance with the Data Protection requirements (GDPR)


The collected data in AMS-ePRO® could be exported or reported based on client wishes.

Get in touch with us at:

AMSEpro s800

• 2021 – New Literature Search tool launched • 2021 – DIGA dossier submission pioneer • 2021 – NIS-eTMF launched • 2021 – MDR readiness, AMS prepared for Medical Device Trials under new regulation • 2021 – VO (EU) 536/2014, AMS among the first 100 participants in the EMA CTIS Trainer Programme • 2021 – eSignature, AMS introduced DocuSign® • 2017 – Globally unique AMS-ePRO® features • 2016 – CRO of the year award •